This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Shire Supports Rare Disease Day 2013

LEXINGTON, Massachusetts, February 28, 2013 /PRNewswire/ --

- Global Initiatives Underscore Company's Long-Term Commitment to the Rare Disease Community

Shire plc (LSE: SHP, NASDAQ: SHPG) today announced its support of Rare Disease Day, joining patients, healthcare providers, and patient organizations around the world to support a day that focuses attention on rare diseases as a public health issue, and highlights the need for more understanding and awareness about these diseases.

Observed annually on the last day of February, Rare Disease Day is coordinated at the international level by the European Organisation for Rare Diseases (EURORDIS) and the National Organization for Rare Disorders (NORD) in the US. The Rare Disease Day 2013 slogan is "Rare Disorders Without Borders" to convey the global solidarity of the rare disease community worldwide and the need for collaboration and mutual support in the field of rare diseases.

According to EURORDIS and NORD there are between 6,000 and 8,000 known rare diseases affecting approximately 30 million Europeans and 30 million Americans. As a leader in rare diseases, Shire's Human Genetic Therapies (HGT) business focuses its work on researching, developing, and marketing therapies for Fabry disease, Hereditary Angioedema, Hunter syndrome, and Gaucher disease, and has built and invested in a pipeline of innovative products and solutions for rare diseases.

"Shire's purpose is to enable people with life-altering conditions to lead better lives - and for us, this includes improving access to information and diagnosis as well as providing much-needed treatment for rare diseases," said Sylvie Grégoire, President of HGT. "Rare Disease Day is an occasion to show our commitment to the rare disease community. We hope that this day can highlight the need for consistent, reliable, and effective treatments and services for patients and give hope to those affected by rare diseases."

1 of 4

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,012.85 -57.55 -0.32%
S&P 500 2,101.44 -13.05 -0.62%
NASDAQ 4,960.9980 -55.9310 -1.11%

Partners Compare Online Brokers

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs